Long, G. V., Lo, S. N., Spillane, A. J., Akkooi, A. C. J. V., Saw, R. P., Pennington, T. E., Shannon, K. F., Martin, L., Coker, D., Ch'ng, S., Guitera, P., London, K., Kapoor, R., Gonzalez, M., Ferguson, P. M., Rawson, R. V., Menzies, A. M. (2026). A phase 2 study of neoadjuvant nivolumab (nivo) + relatlimab (rela) in high-risk stage II cutaneous melanoma (NeoReNi).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9502